Acute Renal Failure With Cocaine and SGLT-2 Inhibitor

被引：2
|
作者：
Shrivastava, Snehal [1 ]
Srivastava, Nishit [2 ]
Alfanso-Jaume, Maria [1 ]
机构：
[1] Univ Toledo, Med Ctr, Div Nephrol, 2801 W Bancroft St, Toledo, OH 43606 USA
[2] Mercy St Vincent Med Ctr, Dept Internal Med, Toledo, OH USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2019年 / 26卷 / 06期
关键词：
ACUTE KIDNEY INJURY; EMPAGLIFLOZIN; DISEASE;
D O I：
10.1097/MJT.0000000000000929
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E762 / E763
页数：3
相关论文
共 50 条
  • [21] Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
    Grempler, R.
    Thomas, L.
    Eckhardt, M.
    Himmelsbach, F.
    Sauer, A.
    Sharp, D. E.
    Bakker, R. A.
    Mark, M.
    Klein, T.
    Eickelmann, P.
    DIABETES OBESITY & METABOLISM, 2012, 14 (01): : 83 - 90
  • [22] Back off to better blow up: acute GFR decrease at SGLT-2 inhibitor initiation
    Laville, Maurice
    KIDNEY INTERNATIONAL, 2021, 99 (04) : 814 - 816
  • [23] Acute kidney injury reduction with SGLT-2 inhibitors?
    Reactions Weekly, 2021, 1883 (1) : 4 - 4
  • [24] Effects Of Sglt-2 Inhibitor Use Among LVAD Patients
    Al Ali, Omar Tayseer
    Pendela, Venkata Satish
    Babayale, Omofolarin
    Faisaluddin, Mohammed
    Parikh, Vishal
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 205 - 205
  • [25] SGLT-2 inhibitor-associated euglycemic ketoacidosis in Denmark
    Johansson, Karl Sebastian
    Bogevig, Soren
    Christensen, Mikkel B.
    CLINICAL TOXICOLOGY, 2024, 62 : 117 - 117
  • [26] Causes of euglycemic Ketoacidosis under SGLT-2 Inhibitor Therapy
    Kahl, Sabine
    DIABETOLOGE, 2019, 15 (05): : 476 - 477
  • [27] Is GFR decline induced by SGLT-2 inhibitor of clinical importance?
    Guenes-Altan, M.
    Bosch, A.
    Striepe, K.
    Schiffer, M.
    Bramlage, P.
    Schmieder, R. E.
    Kannenkeril, D.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S352 - S352
  • [28] IS GFR DECLINE INDUCED BY SGLT-2 INHIBITOR OF CLINICAL IMPORTANCE?
    Guenes-Altan, Merve
    Bosch, Agnes
    Striepe, Kristina
    Schiffer, Mario
    Bramlage, Peter
    Schmieder, Roland E.
    Kannenkeril, Dennis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I87 - I88
  • [29] When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
    Badwan, Osamah Z.
    Braghieri, Lorenzo
    Skoza, Warren
    Agrawal, Ankit
    Menon, Venu
    Tang, W. H. Wilson
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (01) : 47 - 51
  • [30] When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
    Sharma, Aditya
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (04) : 208 - 208
12345